1. Su, Wei-Ming, Gu, Xiao-Jing, Dou, Meng, Wang, Yi, Chen, Yong-Ping. 2023. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease. In Journal of neurology, neurosurgery, and psychiatry, 94, 954-961. doi:10.1136/jnnp-2023-331142. https://pubmed.ncbi.nlm.nih.gov/37349091/
2. Wingo, Aliza P, Liu, Yue, Gerasimov, Ekaterina S, Levey, Allan I, Wingo, Thomas S. 2021. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis. In Nature genetics, 53, 143-146. doi:10.1038/s41588-020-00773-z. https://pubmed.ncbi.nlm.nih.gov/33510477/
3. Zhu, Xiaoming, Li, Yuxin, Yu, Tingting, Li, Sen, Chen, Mulei. 2022. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank. In Gene, 822, 146340. doi:10.1016/j.gene.2022.146340. https://pubmed.ncbi.nlm.nih.gov/35183688/
4. Oguro, Ami, Oida, Shoko, Imaoka, Susumu. 2015. Down-regulation of EPHX2 gene transcription by Sp1 under high-glucose conditions. In The Biochemical journal, 470, 281-91. doi:10.1042/BJ20150397. https://pubmed.ncbi.nlm.nih.gov/26341485/
5. Zhu, X L, Wang, L, Wang, Z, Zhang, W Q, Ma, M M. 2015. Relationship between EPHX2 gene polymorphisms and essential hypertension in Uygur, Kazakh, and Han. In Genetics and molecular research : GMR, 14, 3474-80. doi:10.4238/2015.April.15.11. https://pubmed.ncbi.nlm.nih.gov/25966114/
6. Scott-Van Zeeland, A A, Bloss, C S, Tewhey, R, Kaye, W, Schork, N J. 2013. Evidence for the role of EPHX2 gene variants in anorexia nervosa. In Molecular psychiatry, 19, 724-32. doi:10.1038/mp.2013.91. https://pubmed.ncbi.nlm.nih.gov/23999524/
7. Zhan, Ke, Bai, Yang, Liao, Shengtao, Qiu, Liewang, Mei, Zhechuan. 2021. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma. In Molecular medicine reports, 24, . doi:10.3892/mmr.2021.12289. https://pubmed.ncbi.nlm.nih.gov/34278494/